Projects

Mgr. Silvia Magyarová

National

Current
  • Biomarkers and pathomechanisms of endothelial cell and erythrocyte dysfunction in patients with long COVID and cardiovascular comorbidities
    Program: SRDA
    Duration: 1. 9. 2025 – 31. 8. 2029
  • Identification of stress-induced alterations in expression of NRF2 target genes in rat models of prehypertension: the effect of comorbid hypertriglyceridemia and dimethyl fumarate treatment
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • Cardiovascular protection mediated by alpha 1 AMPK against metabolic syndrome-mediated endothelial dysfunction - identifying new risk factors
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
Finished
  • Hyperuricemia in various comorbidities of the metabolic syndrome - mechanisms of the effect of uric acid on endothelial function and erythrocyte deformability.
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
Employees